Paroxysmal nocturnal hemoglobinuria: Significant association with specific HLA-A, -B, -C, and -DR alleles in an Italian population

Human Immunology

Volumn 69, Issue 3, 2008, Pages 202-206

  Lombardi, Maria Luisa ^a   Terrazzano, Giuseppe ^b   Cosentini, Elena ^b   Gargiulo, Lucia ^c   Risitano, Antonio ^b   Camerlingo, Rosa ^a   Sica, Michela ^b   Aufiero, Daniela ^b   Poggi, Alessandro ^c   Pirozzi, Giuseppe ^a   Luzzatto, Lucio ^d   Rotoli, Bruno ^b   Notaro, Rosario ^c   Alfinito, Fiorella ^b   Ruggiero, Giuseppina ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Alleles; Haplotype; HLA; Immune mediated disease; PNH

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL ARTICLE; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; ITALY; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PIG A GENE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ALLELES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HEMOGLOBINURIA, PAROXYSMAL; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ITALY; MALE; MIDDLE AGED;

EID: 41549102792     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.02.001     Document Type: Article

References (31)

1. Luzzatto L. Paroxysmal nocturnal hemoglobinuria: An acquired X-linked genetic disease with somatic-cell mosaicism. Curr Opin Genet Dev 16 (2006) 317
2. Araten D.J., Nafa K., Pakdeesuwan K., and Luzzatto L. Clonal population of hematopoietic cell with paroxysmal nocturnal hemoglobinuria phenotype are present in normal individuals. Proc Natl Acad Sci U S A 96 (1999) 5209
3. Rosti V., Tremml G., Soares V., Pandolfi P.P., Luzzatto L., and Bessler M. Murine embrionic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest 100 (1997) 1028
4. Luzzatto L., Bessler M., and Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise?. Cell 88 (1997) 1
5. Young N.S., and Maciejewski J.P. The pathophysiology of acquired aplastic anemia. N Engl J Med 336 (1997) 1365
6. Karadimitris A., Manavalan J.S., Thaler H.T., Notaro R., Araten D.J., Roberts I.A., et al. Abnormal T cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 96 (2000) 2613
7. Risitano A., Kook M., Zeng H., Chen G., Young N.S., and Maciejewski J.P. Oligoclonal and policlonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by VβCDR3 spectratyping and flow cytometry. Blood 100 (2002) 178
8. Gargiulo L., Lastraioli S., Cerruti G., Serra M., Loiacono F., Zupo S., et al. Highy homologous T-cell receptor beta sequence support a common target for auto-reactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood 109 (2007) 5036
9. Terrazzano G., Sica M., Becchimanzi C., Costantini S., Rotoli B., Zappacosta S., et al. T cells from paroxysmal nocturnal hemoglobinuria (PNH) patients show an altered CD40-dependent pathway. J Leukoc Biol 78 (2005) 27
10. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13 (1995) 587
11. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., et al. Receptors for HLA class I molecules in human natural killer cells. Annu Rev Immunol 14 (1996) 619
12. Spurkland A., and Sollid L.M. Mapping genes and pathways in autoimmune disease. Trends Immunol 27 (2006) 336
13. Beck S., and Trowsdale J. The human major histocompatibility complex: Lessons from the DNA sequence. Annu Rev Genet 1 (2000) 117
14. Horton R., Wilming L., Rand V., Lovering R.C., Bruford E.A., Khodiyvar V.K., et al. Gene map of the extended human MHC. Nat Rev Genet 5 (2004) 889
15. Maciejewski J.P., Follmann D., Nakamura R., Saunthararajah Y., Rivera C.E., Simonis T., et al. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 98 (2001) 3513
16. Shichishima T., Okamoto M., Ikeda K., Kaneshige T., Sugiyama H., Terasawa T., et al. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 100 (2002) 22
17. Sugimori C., Yamazaky H., Feng X., Mochizuki K., Kondo Y., Takami A., et al. Roles of DRB1*1501 and DRB1*1502 in the pathogenesis of aplastic anemia. Exp Hematol 35 (2007) 13
18. Saunthararajah Y., Nakamura R., Nam J.-M., Robyn J., Loberiza F., Maciejewski J.P., et al. HLA-DR15 (DR2) is overexpressed in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 100 (2002) 1570
19. Shichishima T., Noji H., Ikeda K., Akutsu K., and Maruyama Y. The frequency of HLA class I alleles in Japanese patients with bone marrow failure. Hematologica 91 (2006) 856
20. Parker C., Omine M., Richards S., Nishimura J., Bessler M., Ware R., et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106 (2005) 3699
21. Lombardi M.L., Mercuro O., Ruocco V., Lo Schiavo A., Lombari V., Guerriera V., et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol 113 (1999) 107
22. Villanueva-Flores P.O., Hendel H., Caillat-Zucman S., Rappaport J., Burgos-Tiburcio A., Bertin-Maghit S., et al. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J Immunol 170 (2003) 1925
23. Rendine S., Borelli I., Barbanti M., Sacchi N., Roggero S., and Curtoni E.S. HLA polymorphisms in Italian bone marrow donors: A regional analysis. Tissue Antigens 52 (1998) 135
24. Svejgaard A., and Ryder P. HLA and disease associations: Detecting the strongest association. Tissue Antigens 43 (1994) 18
25. Sette A., and Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50 (1999) 201
26. Ruggiero G., Cosentini E., Zanzi D., Sanna V., Terrazzano G., Matarese G., et al. Allelic distribution of human leucocyte antigen in historical and recently diagnosed tuberculosis patients in Southern Italy. Immunology 111 (2004) 318
27. Jouanguy E., Lambamedi-Cherradi S., Altare F., Fondaneche M.C., Tuerlinckx D., Balnche S., et al. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 100 (1997) 2658
28. Zeng W., Miyazato A., Chen G., Kajigaya S., Young N., and Maciejewskj J.P. Interferon-γ-induced gene expression in CD34 cells: Identification of pathologic cytokine-specific signature profiles. Blood 107 (2006) 167
29. Ou D., Mitchell L.A., and Tingle A.J. A new categorisation of HLA DR alleles on a functional basis. Hum Immunol 59 (1998) 665
30. Imanishi T., Akaza T., Kimura A., Tokunaga K., and Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K., Aizawa M., and Sasazuki T. (Eds). HLA 1991 II (1992), Oxford University Press, Oxford
31. Luzzatto L., and Notaro R. Paroxysmal nocturnal hemoglobinuria. In: Young N.S., Gerson S.L., and High K.A. (Eds). Clinical hematology (2006), Mosby, St. Louis